Saltar al contenido
Merck

Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2014-05-13)
F J Reen, D F Woods, M J Mooij, M N Chróinín, D Mullane, L Zhou, J Quille, D Fitzpatrick, J D Glennon, G P McGlacken, C Adams, F O'Gara
RESUMEN

Chronic respiratory infections are a leading global cause of morbidity and mortality. However, the molecular triggers that cause respiratory pathogens to adopt persistent and often untreatable lifestyles during infection remain largely uncharacterised. Recently, bile aspiration caused by gastro-oesophageal reflux (GOR) has emerged as a significant complication associated with respiratory disease, and cystic fibrosis (CF) in particular. Based on our previous finding that the physiological concentrations of bile influence respiratory pathogens towards a chronic lifestyle in vitro, we investigated the impact of bile aspiration on the lung microbiome of respiratory patients. Sputum samples (n = 25) obtained from a cohort of paediatric CF patients were profiled for the presence of bile acids using high-resolution liquid chromatography-mass spectrometry (LC-MS). Pyrosequencing was performed on a set of ten DNA samples that were isolated from bile aspirating (n = 5) and non-bile aspirating (n = 5) patients. Both denaturing gradient gel electrophoresis (DGGE) and pyrosequencing revealed significantly reduced biodiversity and richness in the sputum samples from bile aspirating patients when compared with non-aspirating patients. Families and genera associated with the pervasive CF microbiome dominated aspirating patients, while bacteria associated with the healthy lung were most abundant in non-aspirating patients. Bile aspiration linked to GOR is emerging as a major host trigger of chronic bacterial infections. The markedly reduced biodiversity and increased colonisation by dominant proteobacterial CF-associated pathogens observed in the sputum of bile aspirating patients suggest that bile may play a major role in disease progression in CF and other respiratory diseases.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Acetonitrilo, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Metanol, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Metanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Acetonitrilo, HPLC Plus, ≥99.9%
Sigma-Aldrich
Metanol, HPLC Plus, ≥99.9%
Sigma-Aldrich
Acetonitrilo, ACS reagent, ≥99.5%
Sigma-Aldrich
Acetonitrilo, anhydrous, 99.8%
Sigma-Aldrich
Acetonitrilo, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Metanol, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
Metanol, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
Metanol, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
Metanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Metanol, Absolute - Acetone free
USP
Metanol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Metanol, BioReagent, ≥99.93%
Supelco
Metanol, analytical standard
Supelco
Metanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Lithocholic acid, ≥95%
Sigma-Aldrich
Deoxycholic acid, ≥98% (HPLC)
Sigma-Aldrich
Chenodeoxycholic acid
Sigma-Aldrich
Cholic acid, from bovine and/or ovine, ≥98%
Sigma-Aldrich
Acetonitrilo, biotech. grade, ≥99.93%
Sigma-Aldrich
Acetonitrilo, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
Metanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Ursodeoxycholic acid, ≥99%
Sigma-Aldrich
Acetonitrilo, suitable for DNA synthesis, ≥99.9% (GC)
Supelco
Acetonitrilo, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Deoxycholic acid, ≥99.0% (T)
Supelco
Acetonitrilo, analytical standard
Sigma-Aldrich
Acetonitrilo, ReagentPlus®, 99%